Prevention and management of severe pre-eclampsia/eclampsia in afghanistan

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Kim, Young M ^a   Ansari, Nasratullah ^a   Kols, Adrienne ^a   Tappis, Hannah ^b   Currie, Sheena ^a   Zainullah, Partamin ^a   Bailey, Patricia ^c   van Roosmalen, Jos ^d   Stekelenburg, Jelle ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Afghanistan; Eclampsia; Emergency obstetric care; Magnesium sulfate; Pre eclampsia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; DIAZEPAM; MAGNESIUM SULFATE;

AFGHANISTAN; ARTICLE; BLOOD PRESSURE CUFF; BREATHING RATE; CASE MANAGEMENT; CONVULSION; DIASTOLIC BLOOD PRESSURE; ECLAMPSIA; EMERGENCY CARE; HEALTH CARE DELIVERY; HEALTH CENTER; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNITY WARD; MIDWIFE; NEEDS ASSESSMENT; NEWBORN CARE; OBSTETRIC PROCEDURE; OXYGEN SATURATION; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANT WOMAN; PUBLIC HOSPITAL; STETHOSCOPE; URINALYSIS; VAGINAL DELIVERY;

AFGHANISTAN; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; CLINICAL COMPETENCE; DIAZEPAM; ECLAMPSIA; EMERGENCY SERVICE, HOSPITAL; EQUIPMENT AND SUPPLIES, HOSPITAL; FEMALE; HEALTH FACILITY SIZE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS; HUMANS; MAGNESIUM SULFATE; MIDWIFERY; OBSTETRICS; PRE-ECLAMPSIA; PREGNANCY;

EID: 84885359568     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-186     Document Type: Article

References (32)

1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367:1066-1074. 10.1016/S0140-6736(06)68397-9, 16581405.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644. 10.1016/S0140-6736(10)60279-6, 20598363.
3. Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, Thorp JM, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Iams JD, Sciscione A, Harper M, Tolosa JE, Saade G, Sorokin Y, Anderson GD. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012, 119:1234-1242. 10.1097/AOG.0b013e3182571669, 3360523, 22617589.
4. Goldenberg RL, McClure EM, Macguire ER, Kamath BD, Jobe AH. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet 2011, 113(2):91-95. 10.1016/j.ijgo.2011.01.002, 21349517.
5. Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health 2011, 11(Suppl 3):S8. 10.1186/1471-2458-11-S3-S8, 3287561, 22375863.
6. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG, HYPITAT study group Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009, 374:979-988. 10.1016/S0140-6736(09)60736-4, 19656558, HYPITAT study group.
7. World Health Organization (WHO) WHO recommendations for prevention and treatment of Pre-eclampsia and eclampsia 2011, Geneva: World Health Organization, World Health Organization (WHO).
8. Duley L, Henderson-Smart D. MgSO4 versus diazepam for eclampsia. Cochrane Database Syst Rev 2003, 4:Art. No CD000127.
9. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from MgSO4? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002, 359:1877-1890.
10. The Eclampsia Trial Collaborative Group Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995, 345:1455-1463. The Eclampsia Trial Collaborative Group.
11. Afghan Public Health Institute Afghanistan mortality survey 2010 2011, Calverton, Maryland: ICF Macro, Afghan Public Health Institute.
12. Central Statistics Organisation (CSO) [Afghanistan] and UNICEF Afghanistan multiple indicator cluster survey 2010-2011: final report 2012, Kabul: UNICEF, Central Statistics Organisation (CSO) [Afghanistan] and UNICEF.
13. UNICEF Emergency Obstetric and Neonatal Care (EmONC) needs assessment in Afghanistan 2010, Kabul: UNICEF, UNICEF.
14. Kim YM, Zainullah P, Mungia J, Tappis H, Bartlett L, Zaka N. Availability and quality of emergency obstetric and neonatal care services in Afghanistan. Int J Gynecol Obstet 2012, 116:192-196.
15. Averting Maternal Death and Disability Program (AMDD) Needs Assessment of Emergency Obstetric and Newborn Care (EmONC): facilitator's guide 2009, New York: Averting Maternal Death and Disability, Averting Maternal Death and Disability Program (AMDD).
16. Hirose A, Borchert M, Niksear H, Alkozai AS, Gardiner J, Fillippi V. The role of care-seeking delays in intrauterine fetal deaths among 'near-miss' women in Herat, Afghanistan. Paediatr Perinat Epidemiol 2012, 26:388-397. 10.1111/j.1365-3016.2012.01299.x, 22882783.
17. Tukur J, Ahonsi B, Mohammed Ishaku S, Araoyinbo I, Okereke E, Babatunde AO. Maternal and fetal outcomes after introduction of MgSO4 for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention. Matern Child Health J 2012, Epub ahead of print.
18. United Nations Commission on Life-Saving Commodities for Women and Children Life-saving commodities http://www.everywomaneverychild.org/resources/un-commission-on-life-saving-commodities/life-saving-commodities, United Nations Commission on Life-Saving Commodities for Women and Children.
19. EngenderHealth Balancing the scales: expanding treatment for pregnant women with life-threatening hypertensive conditions in developing countries 2007, New York: EngenderHealth, EngenderHealth.
20. Smith J, Currie S, Perri J, Bluestone J, Cannon T. National programs for the prevention and management of postpartum hemorrhage and Pre-eclampsia/eclampsia: a global survey 2012 2012, Maternal and Child Health Integrated Program: Washington, DC.
21. Smith JM, Lowe RF, Fullerton J, Currie SM, Harris L, Felker-Kantor E. An integrative review of the side effects related to the use of MgSO4 for pre-eclampsia and eclampsia management. BMC Pregnancy Childbirth 2013, 13:34. 10.1186/1471-2393-13-34, 3570392, 23383864.
22. Dhakal G, Subedi M, Paudel K. MgSO4 in management of severe pre-eclampsia and eclampsia. J Nepal Health Res Counc 2012, 10(21):113-117.
23. Ridge AL, Bero LA, Hill SR. Identifying barriers to the availability and use of MgSO4 Injection in resource poor countries: a case study in Zambia. BMC Health Serv Res 2010, 10:340. 10.1186/1472-6963-10-340, 3018452, 21162717.
24. Frenk J, Chen L, Bhutta ZA, Cohen J, Crisp N, Evans T, Fineberg H, Garcia P, Ke Y, Kelley P, Kistnasamy B, Meleis A, Naylor D, Pablos-Mendez A, Reddy S, Scrimshaw S, Sepulveda J, Serwadda D, Zurayk H. Health professionals for a new century: transforming education to strengthen health systems in an interdependent world. Lancet 2010, 376:1923-1958. 10.1016/S0140-6736(10)61854-5, 21112623.
25. Dumont A, Gaye A, Mahé P, Bouvier-Colle MH. Emergency obstetric care in developing countries: impact of guidelines implementation in a community hospital in Senegal. BJOG 2005, 112:1264-1269. 10.1111/j.1471-0528.2005.00604.x, 16101606.
26. Harvey SA, Ayabaca P, Bucagu M, Djibrina S, Edson WN, Gbangbade S, McCaw-Binns A, Burkhalter BR. Skilled birth attendant competence: an initial assessment in four countries, and implications for the safe motherhood movement. Int J Gynaecol Obstet 2004, 87:203-210. 10.1016/j.ijgo.2004.06.017, 15491581.
27. Firoz T, Sanghvi H, Merialdi M, von Dadelszen P. Pre-eclampsia in low and middle income countries. Best Pract Res Clin Obstet Gynaecol 2011, 25:537-548. 10.1016/j.bpobgyn.2011.04.002, 21592865.
28. Gaym A, Bailey P, Pearson L, Admasu K, Gebrehiwot Y. Ethiopian National EmONC assessment team. Disease burden due to pre-eclampsia/eclampsia and the Ethiopian health system's response. Int J Gynaecol Obstet 2011, 115:112-6. 10.1016/j.ijgo.2011.07.012, 21849170.
29. McCaw-Binns AM, Ashley DE, Knight LP, MacGillivray I, Golding J. Strategies to prevent eclampsia in a developing country: I Reorganization of maternity services. Int J Gynaecol Obstet 2004, 87(3):286-94. 10.1016/j.ijgo.2004.07.008, 15548411.
30. MacGillivray I, McCaw-Binns AM, Ashley DE, Fedrick A, Golding J. Strategies to prevent eclampsia in a developing country: II. Use of a maternal pictorial card. Int J Gynaecol Obstet 2004, 87:295-300. 10.1016/j.ijgo.2004.07.009, 15548412.
31. Peabody JW, Liu A. A cross-national comparison of the quality of clinical care using vignettes. Health Policy Plan 2007, 22(5):294-302. 10.1093/heapol/czm020, 17660225.
32. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 2004, 141:771-80. 10.7326/0003-4819-141-10-200411160-00008, 15545677.